Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
Objective: To compare the effect of sitagliptin (100 mg) vs glimepiride (1–3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). Research design and methods: This 24-week, controlled, open-label study randomized T2DM patients (n = 44...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bioscientifica
2017-11-01
|
| Serie: | Endocrine Connections |
| Soggetti: | |
| Accesso online: | http://www.endocrineconnections.com/content/6/8/748.full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|